X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417 | +145.3% | 382,134 | +334.8% | 0.00% | – |
| Q2 2023 | $170 | – | 87,879 | +87779.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -98.7% | 0.00% | – |
| Q1 2022 | $14,000 | -61.1% | 7,804 | -50.0% | 0.00% | – |
| Q4 2021 | $36,000 | -30.8% | 15,608 | +57.7% | 0.00% | – |
| Q3 2021 | $52,000 | -51.4% | 9,899 | -39.7% | 0.00% | – |
| Q2 2021 | $107,000 | -41.5% | 16,410 | -22.8% | 0.00% | – |
| Q1 2021 | $183,000 | +120.5% | 21,245 | +63.5% | 0.00% | – |
| Q4 2020 | $83,000 | +8200.0% | 12,993 | +9180.7% | 0.00% | – |
| Q2 2020 | $1,000 | -99.5% | 140 | -99.2% | 0.00% | – |
| Q4 2019 | $188,000 | +154.1% | 17,563 | +200.1% | 0.00% | – |
| Q3 2019 | $74,000 | +1750.0% | 5,852 | +2288.6% | 0.00% | – |
| Q1 2019 | $4,000 | – | 245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |